Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 135Pancreatic Neoplasms 36Esophageal Neoplasms 19Biliary Tract Neoplasms 19Colorectal Neoplasms 17Esophageal Squamous Cell Carcinoma 12Neoplasm Metastasis 8Cholangiocarcinoma 8Gastrointestinal Neoplasms 6Colonic Neoplasms 5Advanced Pancreatic Cancer 4Advanced Gastric Cancer 4Rectal Neoplasms 3Gastric Adenocarcinoma 3Gallbladder Neoplasms 3Stage IV Gastric Cancer With Metastasis 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms 2Locally Advanced Pancreatic Cancer 2Locally Advanced Gastric Cancer 2Gastric Cancer Peritoneal Metastases 2Carcinoma, Hepatocellular 2Bile Duct Neoplasms 2Adenocarcinoma 2Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Pancreatic cancer, adult 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Adenocarcinoma 1Metastatic Gastric Adenocarcinoma 1

Interventions

Trastuzumab 5Oxaliplatin 4Capecitabine 3trastuzumab deruxtecan 2tislelizumab 2disitamab vedotin 2Tegafur 2Fluorouracil 2Cisplatin 2tucatinib 1pembrolizumab 1S 1 (combination) 1Ramucirumab 1Paclitaxel 1HMPL-013 1Drug Therapy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HER2-positive Gastric Cancer × S 1 (combination) × Gastrointestinal × Clear all
NCT05586061 2025-02-07

RCTS

Qilu Hospital of Shandong University

Phase 2 Active not recruiting
55 enrolled
Gastrointestinal

HER2-positive Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡